ClinicalTrials.gg
Drug

Olmesartan Medoxomil clinical trials

Also written Benicar and Olmetec.

A product of Olmesartan; its studies count on that page too.

studies test it
46
open now
1
in phase 3
23
first study started
2000

How each study uses Olmesartan Medoxomil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Olmesartan Medoxomil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Apr 2002 · BENICAR · NDA 021286 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Olmesartan medoxomil
28
Olmesartan Medoxomil Tablets 40 mg
2

Brand

Benicar
5
Olmetec
3

In one entry with another drug

Given together, or one or the other

olmesartan medoxomil + hydrochlorothiazide
2

Studies by the year they started

44 studies that test it; most in 2005 (10)

Studies that test Olmesartan Medoxomil, by start year
YearStudies
20001
20011
20022
20033
20044
200510
20065
20072
20084
20095
20102
20111
20141
20151
20191
20261

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
2
Phase 3
23
Phase 4
17

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 37 · Other 9

Daiichi Sankyo (20) · Sankyo Pharma Gmbh (7) · Mylan Pharmaceuticals Inc (2) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (2) · Daiichi Sankyo Co., Ltd. (2) · EMS (2) · Pharmtechnology LLC (1) · Virginia Polytechnic Institute and State University (1)

Often tested with

Tested in the same studies.

Amlodipine (10) · Hydrochlorothiazide (9) · Losartan (4) · Irbesartan (2) · Valsartan (2) · Telmisartan (2) · OLM 40MG (1) · Probenecid (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Olmesartan Medoxomil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 46

See all 46 studies that test Olmesartan Medoxomil →

Given beside what is tested · 3 — Olmesartan Medoxomil is usual care or a partner of the new treatment
As the comparator · 8 — what is tested is compared with Olmesartan Medoxomil

Codes

What other systems call Olmesartan Medoxomil · ClinicalTrials.gg INT006516

  • MeSH (NLM) D000068557Olmesartan MedoxomilConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6M97XTV3HDOLMESARTAN MEDOXOMILConfirmed FDA, NLM, Wikidata
  • RxNorm 118463Confirmed FDA, Wikidata
  • Wikidata Q27888058olmesartan medoxomilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47640Olmesartan MedoxomilOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.